Healthcare / Medical Care FacilitiesBSE
$102.80
-1.70 (-1.63%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-23.6M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
64/100
B
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$338M
P/E
28.6x
↑EV/EBITDA
9.2x
↓ROE
10.0%
↑Gross Margin
23.3%
↓Debt/Equity
0.18
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+20.6%
FCF CAGR
—
FCF margin
9.8%
FCF / Net income
2.35x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $298.7M · net income $12.4M · FCF $29.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $298.7M | $298.7M | $185.2M | $207.3M | $170.4M |
| Net Income | $12.4M | $12.4M | $6.6M | $8.3M | $6.8M |
| EBITDA | $38.8M | $38.8M | $33.2M | $33.0M | $22.5M |
| EPS | 3.79 | 3.79 | 2.02 | 2.96 | 2.07 |
| Gross Margin | 23.3% | 23.3% | 3.0% | 24.6% | 24.8% |
| Operating Margin | 6.1% | 6.1% | -18.1% | 9.2% | 8.7% |
| Net Margin | 4.2% | 4.2% | 3.6% | 4.0% | 4.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.18 | 0.18 | 0.45 | 0.79 | 0.45 |
| Cash Flow | |||||
| Free Cash Flow | $29.3M | $29.3M | $-26.8M | $-23.6M | $-874275.00 |
| Returns | |||||
| ROE | 10.0% | 10.0% | 5.9% | 7.9% | 7.1% |
| Valuation | |||||
| P/E | 28.64 | 28.64 | 7.43 | 5.07 | 7.25 |
| EV/EBITDA | 9.16 | 9.16 | 2.85 | 3.80 | 4.01 |
| P/B | 2.71 | 2.71 | 0.44 | 0.47 | 0.51 |
| Growth & Yield | |||||
| Revenue Growth | 61.3% | 61.3% | -10.6% | 21.6% | — |
| EPS Growth | 87.6% | 87.6% | -31.8% | 43.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
34.0%
EPS terminal req.
$9.12
Spread vs growth
53.6%
5Y implied EPS CAGR
23.8%
EPS terminal req.
$11.04
Spread vs growth
63.8%
10Y implied EPS CAGR
16.7%
EPS terminal req.
$17.78
Spread vs growth
70.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+31.2%
Start / end P/E
38.8x → 27.1x
EPS bridge
2.02 → 3.79
Residual
-26.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.